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afforded by chemosensitive nocicep-
tive neurons, which, when activated, 
drive adaptive behavioral responses. 
The repertoire of receptors identified 
on nociceptors continues to expand, 
and a major surprise of the current 
work is the identification of several 
irritants that activate TRPA1. These 
now include the pungent extracts 
from garlic, mustard oil, acrolein (an 
irritant from tear gas and car exhaust 
fumes), and the metabolic products 
from the chemotherapeutic agent 
cyclophosphamide. It is not estab-
lished that TRPA1 binds all these 
irritants, so an indirect effect is a for-
mal possibility. Although TRPs have 
traditionally been viewed (at least in 
somatosensation) as responding to 
distinct sensory stimuli (Figure 1), the 
work by Bautista et al. (2006) shows 
that multiple agents and mechanisms 
can lead to channel activation.
Perhaps an even more surprising 
finding is that nociceptor responses 
to bradykinin, a much-studied endog-
enous pain mediator, are largely 
attenuated in mice lacking either 
TRPA1 or TRPV1. This is unexpected 
because bradykinin is known to exert 
its actions via B2 receptors, which are 
also expressed by nociceptors. The 
data strongly suggest that ligands 
activating G protein-coupled recep-
tors (GPCRs) coupled to phospholi-
pase C-β (and these are numerous, 
including ATP at P2Y receptors, sero-
tonin at its receptor, 5HT2a, and ace-
tylcholine at muscarinic receptors) 
lead to a form of gating or transacti-
vation of TRPA1. The inward current 
generated in TRP channels by this 
mechanism may thereby integrate 
different stimuli to a cell. The mutual 
dependence of bradykinin responses 
on both TRPA1 and TRPV1 might be 
explained by cumulative Ca2+ entry 
from the two channels but might also 
indicate the importance of TRPA1/V1 
heteromultimers (Figure 1). It is well 
established that all DRG neurons that 
express TRPA1 also express TRPV1.
This work raises not only scientific 
but also organizational issues. As the 
Knockout Mouse Project at the NIH and 
the European Eurocomm programs 
move forward with the aim of deleting 
all mouse genes, how will their efforts 
to monitor mouse phenotypes keep 
pace? It seems doubtful that any of the 
active screens would pick up the inter-
esting features of the TRPA1 knockout 
mouse. Secondly, like other TRP chan-
nels, the principal physiological role 
of TRPA1 remains obscure. Although 
TRPA1 is activated by tear gas and 
other exogenous irritants, it seems 
likely that endogenous activators also 
exist. After the heroic studies using 
expression cloning that have provided 
so much information about TRPs, we 
can now expect an equivalent effort in 
the expression cloning and purification 
of ligands, which should further illumi-
nate the physiological roles of these 
remarkable channels.
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The detailed mechanisms underlying telomere capping and its relationship to telomerase 
activity are still unclear, although many proteins have been implicated in either or both 
processes. In this issue of Cell, Downey et al. (2006) present the surprising identification of 
a new complex, called KEOPS, which promotes both telomere uncapping and elongation.Long before their unusual DNA 
structure or mode of replication was 
known, telomeres were defined by 
their ability to protect chromosome ends from fusion reactions and deg-
radation. This “capping” function has 
been intensively investigated over 
the past 10 years. In yeast, a protein Cell 124, Mcomplex comprised of Cdc13, Stn1, 
and Ten1, together with the Yku70/
Yku80 heterodimer, plays a central 
role in capping. Thus, when raised arch 24, 2006 ©2006 Elsevier Inc. 1125
to the nonpermissive temperature, 
the temperature-sensitive cdc13-1 
mutant experiences extensive deg-
radation of chromosome 5′ ends 
(dependent on the nuclease Exo1) 
that is followed by a RAD9-depend-
ent G2/M checkpoint arrest (Garvik 
et al., 1995). As a consequence, 
deletion of RAD9 (in addition to 
other checkpoint genes) or EXO1 
partially suppress the growth defect 
of cdc13-1.
This was the starting point for 
Downey et al. (2006), who searched 
for new genes involved in capping by 
asking whether other yeast genes, 
when mutated, would suppress the 
growth defect of cdc13-1. To do this 
they crossed the cdc13-1 mutant to 
a collection of ?4800 strains with 
nonessential gene deletions, after 
which haploid double mutant mei-
otic segregants were selected. This 
genome-wide screen identified most 
of the known suppressors of cdc13-
1. These include rad9 and other 
checkpoint mutants, as well as three 
genes involved in nonsense-mediated 
decay, which act by increasing the 
cellular levels of Stn1, thus partially 
restoring function to a weakened 
cdc13-1 protein. Five novel suppres-
sors were also found, one of which 
was a previously uncharacterized 
gene (YML036). Downey et al. (2006) 
decided to further characterize this 
gene, in part because it encodes a 
highly conserved protein, whose 
closest human relative, CGI-121, was 
identified as a binding partner of a 
putative p53 protein kinase, PRPK.
This proved to be an excellent 
choice, as Downey et al. (2006) pro-
vide evidence that Yml036, which 
they rename Cgi121, is part of a pre-
viously unidentified conserved pro-
tein complex that not only affects tel-
omere capping but is also required 
for the maintenance of normal tel-
omere length. They begin by dem-
onstrating that the yeast ortholog 
of PRPK, a poorly characterized 
kinase known as Bud32, interacts 
with Cgi121. Significantly, deletion 
of BUD32 suppresses the cdc13-1 
mutation even more strongly than 
does deletion of CGI121. Using a 
TAP-tag purification approach, they 
then show that Cgi121 and Bud32 1126 Cell 124, March 24, 2006 ©2006 Elsare part of a larger protein complex 
containing Gon7 (a small protein of 
unknown function) and Kae1 (a puta-
tive endopeptidase). Significantly, 
single deletions of CGI121, BUD32, 
or GON7 all result in a short telomere 
phenotype, where the telomeric DNA 
repeat sequence (TG1-3), normally 
300–400 bp in length, is reduced to 
as little as ?100 bp (when BUD32 is 
deleted). Interestingly, KAE1 is an 
essential gene and thus cannot be 
tested. Double mutants do not display 
additional shortening, indicating that 
these proteins act together to pro-
mote telomere elongation, in a com-
plex that the authors name “KEOPS,” 
for kinase, putative endopeptidase, 
and other proteins of small size. The 
short telomere phenotype of KEOPS 
mutants places these proteins in a 
class that includes the yeast ATM 
kinase-like Tel1, the conserved MRX 
(Mre11, Rad50, Xrs2) complex, and 
the Yku70/80 heterodimer. By con-
trast, deletion of these other genes 
does not suppress the loss of cdc13-
1, and in fact, YKU70 deletion seri-
ously compromises growth when 
combined with cdc13-1.
So, why do KEOPS mutants sup-
press the cdc13-1 mutation? Here, 
Downey et al. (2006) provide a very 
clear-cut answer. They show that the 
CGI121 deletion strongly suppresses 
the appearance of single-stranded 
DNA at telomeres in cdc13-1 mutants. 
Deletion of the Bud32 kinase presum-
ably has the same effect, though this 
has not been tested. The conclusion 
is that the KEOPS complex in some 
manner promotes the uncapping 
and/or 5′ end resection of telomeres 
that occurs in cdc13-1 mutants, per-
haps by altering telomere structure 
in some way or by directly promot-
ing the action of Exo1 or another 
 exonuclease.
Downey et al. (2006), however, do 
not dwell on this point but instead 
perform a series of experiments to 
get at the question as to why KEOPS 
mutants have short telomeres. After 
all, this is the key phenotype of 
KEOPS mutants, which appear to 
have no effect on telomere capping 
in CDC13-positive cells. To address 
this question, they first exploit a 
system developed by Kolodner and evier Inc.colleagues to examine a process 
called “telomere healing,” whereby 
telomerase acts at accidental DNA 
double-strand breaks (DSBs) to 
generate a novel telomere (Myung 
et al., 2001). Mutation of PIF1 had 
previously been shown to cause a 
dramatic increase in spontaneous 
telomere healing events, consistent 
with the observation that the Pif1 
helicase acts to remove telomerase 
from native telomeres. Downey et 
al. (2006) show that this increase 
in telomere formation seen in pif1 
mutant cells is abolished by dele-
tion of BUD32, suggesting that the 
KEOPS complex may either regulate 
telomerase recruitment or telomer-
ase activity at DSBs.
To dissect this process in more 
detail, and in cells containing the 
Pif1 helicase, the authors turned to 
an experimental system recently 
described by our own laboratory that 
quantifies telomere formation at an 
induced DSB. In this system it was 
shown that tethering the telomerase 
accessory protein Est1 to the break, 
in the form of a fusion with the Gal4 
DNA binding protein (GBD), strongly 
promotes telomere formation. Strik-
ingly, cells lacking BUD32 are defec-
tive in this GBD-Est1 assay, and the 
authors suggest that this is evidence 
“that Bud32 is not involved in the 
series of events that lead to Est1 
recruitment,” namely the resection of 
DNA ends and the binding of Cdc13 
or Rpa1. Although the results are 
certainly consistent with this idea, 
other interpretations are possible. 
For example, the recruitment of tel-
omerase by GBD-Est1 might initi-
ate the process of telomere forma-
tion, but its successful completion 
might require the full set of reactions 
(which include resection, followed 
by Cdc13 and Rpa1 binding) that 
occur during “normal” telomerase 
replication (Figure 1).
Perhaps with this caveat in mind, 
the authors then examined the effect 
of KEOPS (specifically Bud32) on the 
elongation of telomeres that occurs 
when telomerase subunits are artifi-
cially recruited to native telomeres. 
For these experiments they took 
advantage of observations made by 
Lundblad and colleagues (Evans and 
figure 1. Possible mechanisms of Action for the keoPs complex
The chromosome terminus is indicated by two blue lines. Thicker lines indicate telomeric DNA. The TG strand is in dark blue and the CA strand is in 
light blue. In both (A) and (B), the top drawing represents a telomere in the G1 phase of the cell cycle, with minimal TG overhangs and Est2 bound 
via interaction with Yku. The dual role of KEOPS, as proposed by Downey et al. (2006) is illustrated in (A). In this model, KEOPS promotes resec-
tion of uncapped telomeres in cdc13-1 cells and facilitates Est1 activating function in S phase, through formation of an “open complex,” following 
resection and Cdc13/Rpa loading. The open complex is a state that allows telomerase and other proteins to have physical access to the DNA end of 
the telomere. Est1 is recruited to telomeres through an interaction with Cdc13 (Evans and Lundblad, 1999) and/or Rpa1 (Schramke et al., 2004). (B) 
Alternatively, KEOPS could promote resection and the formation of TG overhangs at telomeres in S phase (the proposed “open state” of replicating 
telomeres), which would then lead to Cdc13- and Rpa1-dependent telomerase recruitment in wild-type cells and to runaway resection in cdc13-1 
cells (indicated by the orange figure, which consists, at least in part, of Exo1), with ensuing checkpoint activation.Lundblad, 1999), who showed that 
fusions of either Est1 or Est2 (the cat-
alytic core of telomerase) to Cdc13 
lead to excessive telomeres elonga-
tion, probably because they short-cir-
cuit the normal recruitment process. 
Notably, Downey et al. (2006) find that 
cells lacking Bud32 are highly defec-
tive in telomere elongation that is trig-
gered by Cdc13-Est hybrids. Again, 
this is consistent with the idea that 
Bud32 acts at some step after tel-
omerase recruitment. They point out 
that the failure of Cdc13-Est1 hybrids 
to promote telomere elongation in 
bud32 mutant cells is reminiscent 
of the failure of Cdc13-Est2 to pro-
mote elongation in cells lacking EST1. 
This may reflect a poorly understood 
function of Est1 in either activation of 
telomerase or promoting its access 
to the telomere 3′ end. The authors 
propose that KEOPS plays a direct 
role in this still mysterious function of 
Est1 (Figure 1A). In further support of 
this notion they show that est1 bud32 
double mutants are no more defective 
in Cdc13-Est2 over-elongation than 
the est1 single mutant.Another way to think about these 
results takes into account the fact 
that Cdc13 binding itself is believed 
to require 5′ end resection to gener-
ate a 3′ G/T-rich single-strand DNA 
overhang. In the absence of normal 
resection it is possible that neither 
native Cdc13 nor Cdc13-Est hybrids 
will have sufficient access to the tel-
omere end to promote elongation. 
Thus, an alternative scenario is that 
the defect in telomere length that is 
observed in KEOPS mutants is due to 
a defect in resection, which leads to 
reduced binding of Cdc13 and Rpa1, 
and ultimately reduced recruitment 
of Est1 and Est2 (Figure 1B). The for-
mation of TG-strand overhangs late 
in S phase is thought to be a critical 
step in telomere maintenance, but the 
mechanism underlying this process 
and its regulation are still very much 
unclear. Although the MRX (Mre11, 
Rad50, Xrs2) complex plays some 
role (Larrivee et al., 2004; Takata et 
al., 2005), the nuclease activity of 
Mre11 is not required. Furthermore, 
overhang length still increases dur-
ing S phase in the absence of MRX, Cell 124, Mas does Cdc13 binding (Takata et al., 
2005; Tsukamoto et al., 2001; Larrivee 
et al., 2004). Although it is untested 
whether KEOPS plays a key role in 
activating or controlling the resec-
tion process at telomeres, such a role 
might explain why KEOPS mutants 
fail to generate the extensive, patho-
logical resection that leads to cell-
cycle arrest in cdc13-1 mutants. A 
more detailed analysis of telomere 
replication in KEOPS mutants, as well 
as identification of KEOPS targets 
(considering both its kinase and puta-
tive endopeptidase activities), will 
certainly help to distinguish between 
these and other models.
In summary, Downey et al. (2006) 
have discovered a new and appar-
ently highly conserved regulator of 
telomere replication and capping. 
This advance emphasizes the tight 
linkage between these two proc-
esses. One theme that emerges from 
this remarkable work is that either the 
access to the telomere by telomerase 
or its activation at the chromosome 
end involves a structural transition at 
the telomere that generates a tran-arch 24, 2006 ©2006 Elsevier Inc. 1127
sient uncapped state. In mammalian 
cells, capping is carried out by a pro-
tein complex, dubbed “shelterin” (de 
Lange, 2005), which may act in part 
by promoting the formation of a pro-
tective structure, the T loop, in which 
the chromosome 3′ single-strand 
terminus is folded back and buried 
in a more internal sequence. Thus, it 
will be interesting to see if and how 
mammalian KEOPS (whose exist-
ence is still hypothetical) impinges 
upon shelterin or other telomeric fac-
tors in mammalian cells.
This elegant study is certain to 
lead to additional important insights 
into both the nature of the telomere 
cap and the mechanism of telom-
erase regulation and highlights the 1128 Cell 124, March 24, 2006 ©2006 Els
Life requires us to make decisions 
every day. Usually, our first step is 
to take the information available and 
process it ourselves. However, when 
crucial decisions arise, we often ask 
advice from friends, family, and col-
leagues. Many times we get varying, 
even opposing, advice and we are 
left with the challenge of weighing 
these suggestions with our own per-
spective of the situation (or with our 
own instincts).
Cells have this problem too. They 
often need to respond simultane-
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Cells often need to respond to 
Janes et al. (2006) show that c
external feedback that involve
with antagonistic functions. T
or survive is not wholly indep
neighbors.close relationship between the two 
that was first revealed by studies of 
Cdc13 (Nugent et al., 1996). The dis-
covery of KEOPS as a new key player 
in telomere function is an exciting 
development that underscores our 
still incomplete understanding of tel-
omere biology, as well as the utility of 
the budding yeast S. cerevisiae, which 
continues to provide new genes with 
which to build models.
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The results are surprising: process-
ing an extracellular signal is not 
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brings to the forefront the importance 
of autocrine signaling in determining 
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